BOSTON--(BUSINESS WIRE)--Flex Pharma, Inc. (NASDAQ: FLKS):
“Etiology and Treatment of Exercise Associated Muscle Cramps”
Flex Pharma, Inc. (NASDAQ: FLKS), today announced that it has launched its cornerstone consumer product, HOTSHOT™, the first scientifically proven formula to prevent and treat muscle cramps, on its branded website www.TeamHOTSHOT.com. The product is also available at selected retailers in Boston, Boulder, and Los Angeles.
For more information, please refer to the press release: SCIENTIFIC BREAKTHROUGH IN SPORTS NUTRITION TO CHANGE THE GAME FOR MILLIONS OF ENDURANCE ATHLETES
At the American College of Sports Medicine Annual Meeting in Boston this afternoon, Bruce Bean, Ph.D., Harvard Medical School Professor of Neurophysiology and Flex Pharma Co-founder and Scientific Advisory Board Co-Chair, and Tom Wessel, M.D., Neurologist and Flex Pharma Chief Medical Officer, will discuss this breakthrough in sports science during the symposium, “Etiology and Treatment of Exercise Associated Muscle Cramps”.
About HOTSHOT
Invented by Rod MacKinnon, a Nobel Prize-winning neuroscientist/endurance athlete, HOTSHOT™ is the sports shot with a kick that is scientifically proven to prevent and treat muscle cramps. A scientific breakthrough in sports nutrition, HOTSHOT is a proprietary formulation of organic ingredients that boosts Neuro Muscular Performance – how an athlete’s nerves and muscles work together in an optimal way. MacKinnon and Harvard neurobiology professor Bruce Bean spent several years calibrating this precise formulation of Transient Receptor Potential (TRP) activator ingredients that stimulate TRP ion channels in the mouth, esophagus and stomach that directly influence and regulate nerve function. Translation? HOTSHOT stops muscle cramps where they start – at the nerve – allowing athletes to push harder, train longer and finish stronger. HOTSHOT is a non-GMO Project Verified, USDA Certified Organic product that is NSF Certified for Sport®. To learn more, visit www.TeamHOTSHOT.com. HOTSHOT is a product of Flex Innovation Group LLC, a division of Flex Pharma, Inc. (Nasdaq FLKS).
HOTSHOT is a consumer product that will be marketed to endurance athletes. HOTSHOT complements the Company’s drug development business and is not intended to diagnose, treat, cure or prevent any disease.
About Flex Pharma
Flex Pharma, Inc. is a biotechnology company that is developing innovative and proprietary treatments for nocturnal leg cramps, cramps and spasms associated with severe neuromuscular conditions such as ALS and MS, and exercise-associated muscle cramps. Flex Pharma was founded by National Academy of Science members Rod MacKinnon, M.D. (2003 Nobel Laureate), and Bruce Bean, Ph.D., recognized leaders in the fields of ion channels and neurobiology, along with Chair and CEO Christoph Westphal, M.D., Ph.D.
Follow Flex Pharma (@flexpharma) and HOTSHOT™, (@Team_HOTSHOT) on Twitter
Flex Pharma, Inc.
Elizabeth Woo, 617-874-1829
SVP, Investor Relations & Corporate Communications
irdept@flex-pharma.com